期刊文献+

DOG1、CD117和PDGFRA在胃肠道间质瘤中的表达及相关性 被引量:5

Expression of DOG1,CD117 and PDGFRA in gastrointestinal stromal tumors
下载PDF
导出
摘要 目的:探讨DOG1、CD117和血小板衍生生长因子受体α(PDGFRA)在胃肠道间质瘤(GISTs)诊断中的意义,并分析与其GISTs临床病理因素和危险度的关系.方法:应用免疫组织化学Envision二步法检测63例GISTs及43例非GISTs间叶源性肿瘤患者中DOG1、CD117及PDGFRA的表达,并分析上述免疫组织化学指标与临床病理因素(性别、年龄、部位、肿瘤大小、核分裂象、组织学类型)和危险度的相关性.结果:GISTs中DOG1、CD117和PDG-FRA阳性表达率分别为84.13%(53/63)、90.48%(57/63)、52.38%(33/63),DOG1、CD117与PDGFRA相比,差异显著(均P<0.01),而其中CD117阴性的6例GISTs均表达DOG1阳性,5例表达PDGFRA阳性;非GISTs间叶源性肿瘤中DOG1、CD117及PDGFRA阳性表达率分别为11.63%、16.28%、6.98%.DOG1及PDGFRA的表达在不同性别、年龄、部位、肿瘤大小、核分裂象、组织学类型之间没有显著性差异,与危险度亦无相关性.但CD117的表达与部位及组织学类型有关(P=0.008,0.045),其他部位(肠系膜、腹腔、网膜)CD117表达率低于胃、小肠、结肠及直肠(50.00%vs94.74%,P=0.008).且梭型及上皮型中CD117高表达.结论:DOG1和CD117可以作为GISTs诊断的特异性标志物;对于KIT阴性的GISTs,DOG1检测的加入,将在病理学和临床上进一步完善诊断依据;DOG1、CD117和PDGFRA不能作为判断危险度的指标. AIM:To investigate the significance of expression of discovered on GIST-1(DOG1),CD117 and platelet-derived growth factor receptor alpha(PDGFRA) in gastrointestinal stromal tumors(GISTs) by analyzing their correlation with clinicopathologic features and risk degree of GISTs.METHODS:The expression of DOG1,CD117 and PDGFRA was detected by immunohistochemistry in 63 cases of GISTs and 43 cases of non-GISTs.The correlation of expression of DOG1,CD117 and PDGFRA with clinicopathologic factors and risk degree of GISTs was then analyzed.RESULTS:The positive expression rates of DOG1,CD117 and PDGFRA in GISTs were 84.13%(53/63),90.48%(57/63) and 3.17%(33/63),respectively.The positive expression rates of DOG1 and CD117 in GISTs were significantly higher than that of PDGFRA(both P 0.01).Of six CD117-negative cases,all were positive for DOG1 and five positive for PDGFRA.The positive expression rates of DOG1,CD117 and PDGFRA in patients with non-GISTs were 11.63%,16.28% and 6.98%,respectively.The expression of DOG1 and PDGFRA had no significant association with gender,age,tumor location,tumor size,mitotic phase,histotype,or risk degree,while the expression of CD117 was related with tumor location and histotyoe(P = 0.008,0.045).Tumors derived from the mesentery,abdominal cavity and epiploon had higher positive rates of CD117 than those derived from the stomach,small intestine,colon and rectum(50.00% vs 94.74%,P = 0.008).CD117 was highly expressed in spindle-cell and epithelial-cell types.CONCLUSION:Both DOG1 and CD117 are highly expressed in GISTs and can serve as specific diagnostic markers for GISTs.DOG1 has a good sensitivity and specificity in the diagnosis of GISTs,especially KIT-negative GISTs.Detection of DOG1,CD117 and PDGFRA expression can not be used for assessing the risk degree of GISTs.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第9期912-918,共7页 World Chinese Journal of Digestology
关键词 胃肠道间质瘤 DOG1 KIT蛋白 血小板衍生生长因子受体α 临床病理因素 危险度 Gastrointestinal stromal tumor Discovered on GIST-1 Kit Platelet-derived growth factor receptor alpha Clinicopathologic features Risk degree
  • 相关文献

参考文献33

  • 1Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol 2009; 33: 1401-1408.
  • 2Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008; 39: 1411-1419.
  • 3中国胃肠道间质瘤病理共识意见[J].中华病理学杂志,2007,36(10):704-707. 被引量:110
  • 4Rossi CR, Mocellin S, Mencarelli R, Foletto M, Pilati P, Nitti D, Lise M. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer 2003; 107: 171-176.
  • 5Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005; 29: 52-68.
  • 6Dow N, Giblen G, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol 2006; 23: 111-119.
  • 7Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, Safioleas M. Gastrointestinal stromal tumor. World J Surg Oncol 2009; 7: 61.
  • 8陈金培,刘国荣,杨耀湘.CD117、CD34、Ki-67在胃肠道间质瘤中的表达及意义[J].世界华人消化杂志,2009,17(29):3043-3047. 被引量:11
  • 9Bórquez Ma P, Neveu C R. [Gastrointestinal stromal tumors. An update]. Rev Med Chil 2008; 136: 921-929.
  • 10朱玉春,王建良,周伟,吴志娟,沈纪芳.胃肠道间质瘤的螺旋CT征象与其良恶性的相关性分析[J].实用临床医药杂志,2010,14(5):127-129. 被引量:2

二级参考文献73

共引文献157

同被引文献58

  • 1Borislav Belev,Iva Bri,Juraj Prejac,Zrna Antunac Golubi,Damir Vrbanec,Jadranka Bozikov,Ivan Aleri,Marko Boban,Jasminka Jaki Razumovi.Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors[J].World Journal of Gastroenterology,2013,19(4):523-527. 被引量:14
  • 2白月奎,邵永孚,石素胜,高燕宁,孙耘田,万玉良.小肠间质瘤预后因素分析[J].中华胃肠外科杂志,2005,8(3):213-216. 被引量:16
  • 3Atik M, Whittlesey RH. Liposarcoma of jejunum. Ann Surg 1957; 146: 837-842 PubMed DOI.
  • 4Mohandas D, Chandra RS, Srinivasan V, Bhaskar AG. Liposarcoma of the ileum with secondaries in the liver. Am J Gastroenterol 1972; 58: 172-176 PubMed.
  • 5Wood DL, Morgenstern L. Liposarcoma of the ileocecal valve: a case report. Mt Sinai J Med 1989; 56: 62-64 PubMed.
  • 6Bianchi E, De Monti M, Miani S, Stringhi E, Scorza R. [Malignant neoplasia of the small intestine. Apropos of 7 cases. Clinical discussion and review of the literature]. Minerva Chir 1998; 53: 289-298 PubMed.
  • 7De Monti M, Mangoni I, Gobatti D, Ghilardi G, Scorza R. [Primary jejunal liposarcoma]. Minerva Gastroenterol Dietol 2000; 46: 119-122 PubMed.
  • 8Atik M, Whittlesey RH. Liposarcoma of jejunum.Ann Surg 1957; 146: 837-842 PubMed DOI.
  • 9Christopher DM. Fletcher, Julis A. Bridge, Pancras C.W.Hogendoorn, Fredrik Mertens. WHO Classification of Tumours of Soft and Bone. WHO, 2013: 39-41.
  • 10Bosman FT, Carneiro F, Hruban RH, Theise ND (EDS). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, 2010, 115-116.

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部